The board of directors of biopharmaceutical company Pfizer Inc (NYSE:PFE) approved a dividend payment of USD0.38 per share on the company's common stock for the first-quarter 2020, it declared on Monday.
Pfizer stated that the 6% higher quarterly payment reflects its 325th consecutive quarterly dividend.
This dividend will be paid on 6 March 2020 to holders of the common stock of record at the close of business as of 31 January 2020.
Also, the company said it plans to host an Investor Day at 9:00 a.m. EDT on 31 March 2020, at its global headquarters in New York, NY, to provide updates on its progress in advancing its R&D pipeline, product candidates with blockbuster potential that are expected to launch by 2025.
Pfizer collaborates with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world.
CVS Health declares unchanged quarterly dividend
ALK partners with GenSci to expand allergy immunotherapy market in China
Curatis secures Swiss distribution deal with Phoenix Labs
Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo
Essa Pharma clarifies Nasdaq due bill trading period for cash distribution
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli
Heron Therapeutics announces tax benefits preservation plan adoption
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
Everest Medicines expands I-MAB investment
Perrigo Announces Quarterly Dividend
Ridgetech reports net income of USD10.20m in fiscal year 2025